Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy

Oral Oncology

Volumn 48, Issue 10, 2012, Pages 964-968

  Huang, Pei Yu ^a   Li, Yan ^a   Mai, Hai Qiang ^a   Luo, Rong Zhen ^a   Cai, Yu Chen ^a   Zhang, Li ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Cisplatin; ERCC1; Induction chemotherapy; Nasopharyngeal carcinoma; Prognostic factor

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL; DISTANT FAILURE FREE SURVIVAL; FAILURE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; LOCAL FAILURE FREE SURVIVAL; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CISPLATIN; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; FLUOROURACIL; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866405470     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.04.003     Document Type: Article

References (22)

1. J.A. Langendijk, C.R. Leemans, J. Buter, J. Berkhof, and B.J. Slotman The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 2004 4604 4612
2. B. Baujat, H. Audry, J. Bourhis, A.T. Chan, H. Onat, and D.T. Chua Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 2006 47 56
3. D.T. Chua, J. Ma, J.S. Sham, H.Q. Mai, D.T. Choy, and M.H. Hong Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 2005 1118 1124
4. A.W. Lee, W.H. Lau, S.Y. Tung, D.T. Chua, R. Chappell, and L. Xu Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 2005 6966 6975
5. A.T. Chan, P.M. Teo, R.K. Ngan, T.W. Leung, W.H. Lau, and B. Zee Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial J Clin Oncol 20 2002 2038 2044
6. K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. Andre, and V. Haddad DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
7. S.A. Leibel, C.B. Scott, M. Mohiuddin, V.A. Marcial, L.R. Coia, and L.W. Davis The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database Int J Radiat Oncol Biol Phys 21 1991 549 556
8. B.B. Ma, E.P. Hui, and A.T. Chan Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions Cancer Sci 99 2008 1311 1318
9. S.H. Kim, H.C. Kwon, S.Y. Oh, D.M. Lee, S. Lee, and J.H. Lee Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer Am J Clin Oncol 32 2009 38 43
10. A. Handra-Luca, J. Hernandez, G. Mountzios, E. Taranchon, J. Lacau-St-Guily, and J.C. Soria Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma Clin Cancer Res 13 2007 3855 3859
11. H.W. Lee, Y.H. Hwang, J.H. Han, J.H. Choi, S.Y. Kang, and S.H. Jeong High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer Oral Oncol 46 2010 209 213
12. S.H. Chan, F.M. Cheung, W.T. Ng, C.W. Choi, K.N. Cheung, and K.H. Yiu Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 79 2011 1414 1420
13. J.M. Sun, M.J. Ahn, M.J. Park, H.Y. Lee, J.S. Ahn, and S. Lee Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy Int J Radiat Oncol Biol Phys 80 2011 655 660
14. F. Cheung, O. Chan, W.T. Ng, L. Chan, A. Lee, and S.W. Pang The prognostic value of histological typing in nasopharyngeal carcinoma Oral Oncol 2011
15. I.D. Fleming, J.S. Cooper, and D.E. Henson American Joint Committee on Cancer: AJCC cancer staging manual 5th ed. 1997 Lippincott-Raven Philadelphia, PA
16. L.H. Sobin, and W. Ch International Union Against Cancer (UICC): TNM classification of malignant tumors 5th ed. 1997 Wiley-Liss New York, NY 25-32
17. L. Tai-Xiang, L. Wei, and Z. Chong A probe of design methods of block shielding facio cervical portals at isocentre for radiotherapy of nasopharyngeal carcinoma Ai Zheng 19 2000 930 933
18. Y.M. Lo, A.T. Chan, L.Y. Chan, S.F. Leung, C.W. Lam, and D.P. Huang Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA Cancer Res 60 2000 6878 6881
19. D.T. Chua, J.M. Nicholls, J.S. Sham, and G.K. Au Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 59 2004 11 20
20. B.B. Ma, E.P. Hui, S.C. Wong, S.Y. Tung, K.K. Yuen, and A. King Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma-correlation with excision repair cross-complementing-1 polymorphisms Ann Oncol 20 2009 1854 1859
21. N. Lee, P. Xia, J.M. Quivey, K. Sultanem, I. Poon, and C. Akazawa Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience Int J Radiat Oncol Biol Phys 53 2002 12 22
22. W.T. Ng, M.C. Lee, W.M. Hung, C.W. Choi, K.C. Lee, and O.S. Chan Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 79 2011 420 428